PeptiDream Inc. and PDRadiopharma Inc. (PeptiDream Group)

Greenhouse gas emissions & sustainability report data

📊 Latest report period: FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma)🗂️ Report periods on file: FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma), 2023, 2021, 2020

In its FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma) reporting, PeptiDream Inc. and PDRadiopharma Inc. (PeptiDream Group) disclosed greenhouse gas emissions of 0 tCO2e (Scope 1+2) in FY2022. Figures are as stated in the company's own report and may use different boundaries, units or methods (for example market-based vs location-based Scope 2), so compare with care.

💨
GHG Emissions
0 tCO2e (Scope 1+2) in FY2022
FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma)
⚡
Renewable Energy
100% of electricity from renewable sources in 2022
of total energy

📈 Emissions by Report Period

Report periodHeadline emissions figure reported
FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma)0 tCO2e (Scope 1+2) in FY2022
20217.72 tCO2e/year (2021); 0 tCO2e/year (2022)
20201.4K tCO2e/year

Each row is the headline figure extracted from a different report; scope coverage and methodology can change between years.

✅ Reported Environmental Achievements

🌱 ESG Focus Areas

Climate Change/CO2 Emission ReductionWaste ReductionBiodiversity ConservationResponsible Sourcing/Stable Product SupplyCommunity RelationsCorporate GovernanceCompliance and Risk ManagementCultivating a culture of innovation/Ensuring diversity in core human resourcesRespecting human rights/Occupational health and safetyAddressing unmet medical needs through the discovery of transformational medicinesStakeholder Engagement

⚠️ Challenges & Risks +

  • Potential business interruption due to natural disasters (flooding) affecting facilities and infrastructure in Tonomachi, Kawasaki City.
  • Cybersecurity threats

📋 Report Information

Reporting Period: FY2022 (PeptiDream); March 28, 2022 to December 31, 2022 (PDRadiopharma)
Frameworks: TCFD